SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:kth-197610"
 

Sökning: id:"swepub:oai:DiVA.org:kth-197610" > Molecular pathology...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002955naa a2200385 4500
001oai:DiVA.org:kth-197610
003SwePub
008161205s1997 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-1976102 URI
024a https://doi.org/10.1038/sj.onc.12014352 DOI
040 a (SwePub)kth
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Pontén, F4 aut
2451 0a Molecular pathology in basal cell cancer with p53 as a genetic marker.
264 1b Springer Science and Business Media LLC,c 1997
338 a print2 rdacarrier
500 a QC 20161206
520 a Human basal cell cancer (BCC) has unique growth characteristics with virtual inability to metastasize. We investigated clonality and genetic progression using p53 mutations as marker. Sampling was done through microdissection of frozen immunohistochemically stained 16 microm slices of tumors. From 11 BCC tumors 78 samples were analysed. Direct DNA sequencing of exons 5-8 was performed, haplotypes were determined after cloning of p53 exons and loss of heterozygosity (LOH) ascertained by microsatellite analysis. All tumors had p53 mutations and in a majority both p53 alleles were affected, commonly through missense mutations. Microdissection of small parts (50-100 cells) of individual tumors showed BCC to be composed of a dominant cell clone and prone to genetic progression with appearance of subclones with a second and even third p53 mutation. Samples from normal immunohistochemically negative epidermis always showed wild type sequence, except for a case of previously unknown germline p53 mutation. Our analysis also included p53 immunoreactive patches i.e. morphologically normal epidermis with a compact pattern of p53 immunoreactivity. Mutations within those were never the same as in the adjacent BCC. This detailed study of only one gene thus uncovered a remarkable heterogeneity within a tumor category famous for its benign clinical behavior.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Cell- och molekylärbiologi0 (SwePub)301082 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Cell and Molecular Biology0 (SwePub)301082 hsv//eng
700a Berg, Cecilia,d 1969-u KTH,Proteomik och nanobioteknologi4 aut0 (Swepub:kth)u1ygqmuy
700a Ahmadian, A4 aut
700a Ren, Z P4 aut
700a Nistér, M4 aut
700a Lundeberg, J4 aut
700a Uhlén, M4 aut
700a Pontén, J4 aut
710a KTHb Proteomik och nanobioteknologi4 org
773t Oncogened : Springer Science and Business Media LLCg 15:9q 15:9x 0950-9232x 1476-5594
856u https://www.nature.com/articles/1201435.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-197610
8564 8u https://doi.org/10.1038/sj.onc.1201435

Hitta via bibliotek

  • Oncogene (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy